Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

11.14
Delayed Data
As of Jul 28
 +0.11 / +1.00%
Today’s Change
8.34
Today|||52-Week Range
15.51
-22.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues31.3M32.7M33.9M50.2M
 
 
 
 
 
Cost of Goods Sold0.00129.0K0.001.6M
 
 
 
Depreciation And Amortization2.0M2.1M1.9M2.8M
 
 
 
 
 
 
Operating ExpensesGross Income29.3M30.5M32.0M45.8M
 
 
 
 
 
General Expenses40.0M57.9M52.4M102.7M
 
 
 
 
 
Research And Development29.0M44.5M28.0M19.2M
 
 
 
 
 
Total Operating Expenses42.0M60.2M54.3M107.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.7M-27.4M-20.4M-57.0M
 
 
 
 
 
Extraordinary Credit0.000.000.0077.6M
 
 
Extraordinary Charge0.00-800.0K0.00-600.0K
 
 
 
Other Expenses0.000.00145.0K124.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.2M-27.7M-20.3M20.2M
 
 
 
 
 
Income Taxes-444.0K0.000.000.00
 
 
Net Income-9.8M-27.7M-20.3M20.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.1M28.2M30.4M34.8M
 
 
 
 
 
Shares To Calculate EPS Diluted28.1M28.2M30.4M36.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.98-$0.67$0.55
 
 
 
 
 
EPS Diluted-$0.35-$0.98-$0.67$0.55
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account